Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis

  • Talya Salz
  • , Susan Chimonas
  • , Sankeerth Jinna
  • , Jessica Brens
  • , Anuja Kriplani
  • , Andrew Salner
  • , Guilherme Rabinowits
  • , Beatriz Currier
  • , Bobby Daly
  • , Deborah Korenstein

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Aim: We aimed to understand experiences with opioids and cannabis for post-treatment cancer survivors. Patients & methods: We conducted seven focus groups among head and neck and lung cancer survivors, using standard qualitative methodology to explore themes around 1) post-treatment pain and 2) utilization, perceived benefits and perceived harms of cannabis and opioids. Results & conclusion: Survivors (N = 25) experienced addiction fears, stigma and access challenges for both products. Opioids were often perceived as critical for severe pain. Cannabis reduced pain and anxiety for many survivors, suggesting that anxiety screening, as recommended in guidelines, would improve traditional pain assessment. Opioids and cannabis present complex harms and benefits for post-treatment survivors who must balance pain management and minimizing side effects.

Original languageEnglish
Pages (from-to)87-99
Number of pages13
JournalPain Management
Volume14
Issue number2
DOIs
StatePublished - 2024

Keywords

  • cancer
  • cancer survivors
  • cannabis
  • head and heck neoplasms
  • opioid

Fingerprint

Dive into the research topics of 'Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis'. Together they form a unique fingerprint.

Cite this